Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 1
2019 3
2020 7
2021 10
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Peptide Vaccines for Leishmaniasis.
De Brito RCF, Cardoso JMO, Reis LES, Vieira JF, Mathias FAS, Roatt BM, Aguiar-Soares RDDO, Ruiz JC, Resende DM, Reis AB. De Brito RCF, et al. Front Immunol. 2018 May 11;9:1043. doi: 10.3389/fimmu.2018.01043. eCollection 2018. Front Immunol. 2018. PMID: 29868006 Free PMC article. Review.
Recent advances and new strategies on leishmaniasis treatment.
Roatt BM, de Oliveira Cardoso JM, De Brito RCF, Coura-Vital W, de Oliveira Aguiar-Soares RD, Reis AB. Roatt BM, et al. Appl Microbiol Biotechnol. 2020 Nov;104(21):8965-8977. doi: 10.1007/s00253-020-10856-w. Epub 2020 Sep 2. Appl Microbiol Biotechnol. 2020. PMID: 32875362 Review.
Recent advances and new strategies in Leishmaniasis diagnosis.
De Brito RCF, Aguiar-Soares RDO, Cardoso JMO, Coura-Vital W, Roatt BM, Reis AB. De Brito RCF, et al. Appl Microbiol Biotechnol. 2020 Oct;104(19):8105-8116. doi: 10.1007/s00253-020-10846-y. Epub 2020 Aug 26. Appl Microbiol Biotechnol. 2020. PMID: 32845368 Review.
An attenuated herpesvirus vectored vaccine candidate induces T-cell responses against highly conserved porcine reproductive and respiratory syndrome virus M and NSP5 proteins that are unable to control infection.
de Brito RCF, Holtham K, Roser J, Saunders JE, Wezel Y, Henderson S, Mauch T, Sanz-Bernardo B, Frossard JP, Bernard M, Lean FZX, Nunez A, Gubbins S, Suárez NM, Davison AJ, Francis MJ, Huether M, Benchaoui H, Salt J, Fowler VL, Jarvis MA, Graham SP. de Brito RCF, et al. Front Immunol. 2023 Aug 3;14:1201973. doi: 10.3389/fimmu.2023.1201973. eCollection 2023. Front Immunol. 2023. PMID: 37600784 Free PMC article.
Development of an immunogen containing CD4+/CD8+ T-cell epitopes for the prophylaxis of tegumentary leishmaniasis.
de Andrade Ferraz I, Carvalho AMRS, de Brito RCF, Roatt BM, Martins VT, Lage DP, Dos Reis Cruz L, Medeiros FAC, Gonçalves DU, da Costa Rocha MO, Coelho EAF, de Oliveira Mendes TA, Duarte MC, Menezes-Souza D. de Andrade Ferraz I, et al. Appl Microbiol Biotechnol. 2022 Jun;106(12):4627-4641. doi: 10.1007/s00253-022-12033-7. Epub 2022 Jun 27. Appl Microbiol Biotechnol. 2022. PMID: 35759035 Free PMC article.
Multiplex flow cytometry serology to diagnosis of canine visceral leishmaniasis.
Ker HG, Coura-Vital W, Valadares DG, Aguiar-Soares RDO, de Brito RCF, Veras PST, Fraga DBM, Martins-Filho OA, Teixeira-Carvalho A, Reis AB. Ker HG, et al. Appl Microbiol Biotechnol. 2019 Oct;103(19):8179-8190. doi: 10.1007/s00253-019-10068-x. Epub 2019 Aug 6. Appl Microbiol Biotechnol. 2019. PMID: 31388731
Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.
Carvalho LM, Gusmão MR, Costa AFP, de Brito RCF, Aguiar-Soares RDO, Cardoso JMO, Reis AB, Carneiro CM, Roatt BM. Carvalho LM, et al. Parasitology. 2022 Mar;149(3):371-379. doi: 10.1017/S0031182021001906. Epub 2021 Nov 2. Parasitology. 2022. PMID: 35264268 Free PMC article.
Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB. Cardoso JMO, et al. Mol Immunol. 2022 Jan;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20. Mol Immunol. 2022. PMID: 34814056
28 results